Curaleaf Increases Offer to Acquire Aurora Cannabis
Curaleaf Holdings has increased its offer for Aurora Cannabis, raising the total implied consideration by 25% to $5.00 per share and offering a premium of 86% over Aurora's unaffected share price as of August 10, 2026. The revised proposal includes more cash—$1.00 per share—and an increase in Curaleaf shares offered from the initial deal structure. The enhanced offer is based solely on publicly available information and aims to provide Aurora shareholders with a stake in what would become one of the largest global cannabis platforms, combining operations across 17 countries and generating over $1.5 billion in last-twelve-month revenue. Curaleaf's CEO emphasized that despite Aurora’s refusal to allow due diligence access, they remain committed to engaging constructively. The deal is seen as a strategic move toward creating significant value for shareholders through consolidation of the two major cannabis players.
Topics: Cannabis Corporate Acquisition Stock Offer